SAN DIEGO, April 8, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ImmunityBio, Inc. (NASDAQ: IBRX) publicly traded securities between January 19, 2026 ...
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ImmunityBio, Inc., (“Super Micro” or the "Company") (NASDAQ: IBRX) investors of a class action on behalf of investors that ...
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ImmunityBio, Inc. (NASDAQ: ...
Hosted on MSN
CBSE Class 12 biology exam 2026: Expert tips and high-probability questions you must practice
The Central Board of Secondary Education (CBSE) will conduct the Class 12 Biology exam 2026 on Friday, March 27. It is considered a crucial subject for Science stream students, as excelling in Biology ...
IMMUNITYBIO, INC. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY: The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well ...
The MarketWatch News Department was not involved in the creation of this content. INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results